Reseligo 3,6 mg implant in pre - filled syringe
Country: Bulgarija
Lingwa: Bulgaru
Sors: Изпълнителна агенция по лекарствата
Fuljett ta 'informazzjoni
(PIL)
06-03-2023
Karatteristiċi tal-prodott
(SPC)
06-03-2023
Ingredjent attiv:
Гозерелин
Disponibbli minn:
Alvogen IPCo.S.ar. I.
Kodiċi ATC:
L02AE3
INN (Isem Internazzjonali):
Goserelin
Dożaġġ:
3,6 mg implant in pre - filled syringe
Sommarju tal-prodott:
Reseligo, 3,6 mg implant in pre-filled syringe - x 1; x 3
Data ta 'l-awtorizzazzjoni:
2015-11-10
